1 / 10

RSV

RSV. RT 265. Respiratory Syncytial Virus. Manifests primarily as: Bronchiolitis Viral pneumonia Leading cause of lower respiratory tract infection in infants. Syncytium:. Multinucleate mass of protoplasm produced by the merging of neighboring cells. Incidence. Peak ages 2-8months

reece-oneill
Download Presentation

RSV

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RSV RT 265

  2. Respiratory Syncytial Virus Manifests primarily as: • Bronchiolitis • Viral pneumonia Leading cause of lower respiratory tract infection in infants

  3. Syncytium: Multinucleate mass of protoplasm produced by the merging of neighboring cells

  4. Incidence • Peak ages 2-8months • Usually >4years old • Mid-winter and spring months • Virtually all children have been exposed by 3rd birthday • Disease is mild in older children and adults (upper respiratory tract) • WHY THE LITTLE ONES? • Smaller airways • Reduced immune system • High-risk groups for severe RSV infection include the following: • premature infants in their first year of life (the younger the child is [gestational and chronological age] at the start of RSV season, the greater the risk) • Infants with chronic lung disease (eg, bronchopulmonary dysplasia,cystic fibrosis) during their first 2 years of life • Children with hemodynamically significant congenital heart disease, especially with increased pulmonary blood flow • Immunodeficient states • Children with metabolic and neuromuscular disorders • Children of multiple births (triplets or greater)

  5. Diagnosis • Correlate symptoms with the time of year, presence of a regional outbreak, patient age, and history of the illness • Specific diagnostics testing: • Nasal swabs • Nasal lavage • Nasopharyngeal aspiration • CXR hyperinflation diffuse increase in interstitial markings

  6. Presentation • Fever • Cough • Tachypnea • Retractions • Wheezing • Crackles • Sepsis like symptoms • Apneic episodes in the very young • Diffuse small airway disease

  7. Management Supportive care Can be managed at home unless requiring: • Supplemental oxygen • Fluid replacement – normal feeding or IV if unable • Bronchial hygiene - suctioning • Bronchodilators? (alpha and beta agonists) • Ribavirin (Virazole) • Mechanical ventilation/CPAP Prevention • WASH YOUR HANDS • Avoid mucus membrane exposure • Palivizumab (Synagis) antiviral immunoglobulins /motavizumab (investigational – not FDA approved)

  8. The “best” part: No lifelong immunity develops! Reinfection is common 

More Related